SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
15.00
Ask:
17.00
Spread: 2.00 (13.333%)
Market Cap: £17.55m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Form 8.5 (EPT/RI)

14 Apr 2021 07:58

RNS Number : 4250V
Canaccord Genuity Limited
14 April 2021
 

 

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Team Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeror

(Team Plc)

(d) Date dealing undertaken:

13 April 2021

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD NPV

 

 

Purchases

 

 

10,113

 

 

83p

 

 

83p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

14 April 2021

Contact name:

David Baker

Telephone number:

020 7523 4656

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERKZGMDVDVGMZG
Date   Source Headline
22nd Jun 20227:00 amRNSHalf-year Report
7th Jun 20229:15 amRNSNotice of AGM
16th May 20225:30 pmRNSDirector/PDMR Shareholding
16th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20227:05 amRNSChanges to Management Incentive Plan
12th May 20227:00 amRNSProposed Acquisition, Subscription &Trading Update
23rd Feb 20227:00 amRNSIssue of Equity
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:01 amRNSFinal Results
1st Dec 20217:00 amRNSAcquisition
5th Oct 202110:30 amRNSChange of Registered Office
26th Aug 20211:10 pmRNSDirector/PDMR Shareholding
10th Aug 202110:45 amRNSDirector/PDMR Shareholding
5th Jul 202111:05 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSAcquisition of JCAP Limited
24th May 20217:00 amRNSDirector Dealing
21st May 20217:00 amRNSInterim Results
20th May 20216:00 pmRNSResult of AGM
29th Apr 20217:00 amRNSNotice of AGM
23rd Apr 20219:45 amRNSForm 8.5 (EPT/RI)
22nd Apr 20218:30 amRNSForm 8.5 (EPT/RI)
20th Apr 20214:30 pmRNSUpdate on Possible Offer
20th Apr 20217:54 amRNSForm 8.5 (EPT/RI)
19th Apr 20219:59 amRNSUpdate re support to reject possible offer by TEAM
16th Apr 202111:18 amRNSUpdate re support to reject possible offer by TEAM
15th Apr 202112:00 pmRNSUpdate re support to reject possible offer by TEAM
14th Apr 202112:31 pmRNSSupport to reject any possible offer by TEAM plc
14th Apr 20217:58 amRNSForm 8.5 (EPT/RI)
13th Apr 20218:17 amRNSForm 8.5 (EPT/RI)
12th Apr 20217:23 amRNSForm 8.5 (EPT/RI)
9th Apr 202111:40 amRNSUpdate on Letters of Intent
8th Apr 20212:30 pmRNSForm 8.3 - [Odin Investment Management Ltd]
8th Apr 20211:00 pmRNSForm 8.3 - [Sami Haidar / Prima]
8th Apr 202112:59 pmRNSForm 8.3 - [Bubbles Investments Limited]
8th Apr 202111:30 amRNSForm 8 (OPD) (TEAM plc) (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [Peter McKellar] (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [Mark Clubb] (Replacement)
8th Apr 20217:00 amRNSForm 8 (OPD) (TEAM plc) (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [Sally Mears] (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [John Dixon] (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [Ian Hannam] (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [John Drinkwater] (Replacement)
8th Apr 20217:00 amRNSForm 8.3 - [Loreto Ltd] (Replacement)
7th Apr 20216:23 pmRNSForm 8.3 - [Sally Mears]
7th Apr 20216:22 pmRNSForm 8.3 - [Quantum Field Dynamics]
7th Apr 20216:20 pmRNSForm 8.3 - [Peter McKellar]
7th Apr 20216:19 pmRNSForm 8.3 - [Martin Gilbert]
7th Apr 20216:16 pmRNSForm 8.3 - [Lance Trevellyan]
7th Apr 20216:16 pmRNSForm 8.3 - [Mark Clubb]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.